firc institute of molecular oncology



Professor and Director, Institute for Cancer Genetics

Dr. Dalla-Favera has provided key leadership to the cancer research community at Columbia University Medical Center, particularly in his roles as founding Director of the Institute for Cancer Genetics, and from 2005-2011, as Director of the Herbert Irving Comprehensive Cancer Center.

As a researcher, he has contributed much of the current knowledge on the genetic lesions responsible for human B cell lymphoma. The molecular lesions identified by Dr. Dalla-Favera have led to the development of diagnostic tests and are being tested as targets in clinical trials with lymphoma patients. His work is widely quoted in scientific publications and in medicine and oncology textbooks.

Dr. Dalla-Favera has been recognized with several national awards, including the 2006 William Dameshek Prize for Outstanding Contribution to Hematology from The American Society of Hematology. In 2011 he was elected to the Institute of Medicine of the National Academy of Sciences, USA, and in 2012, received the National Cancer Institute’s Alfred Knudson Award.

Dalla-Favera's article

August 2014

Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis

Commentary on Stefano Casola's paper published on The Journal of Clinical Investigation.